blog.aids.gov − HIV Vaccine
AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV - Changing to HIV.gov in Spring 2017

MENU

HIV Vaccine

Prevention Studies In 2016 Set the Stage for Progress

It is fitting that in the year that we marked the 35th anniversary of the first recognition of what would come to be known as HIV, we’ve taken major steps toward revolutionizing how we could prevent this disease. In 2016 we began four important clinical studies that promise to inform HIV prevention research, which may…

NIH’s Dr. Carl Dieffenbach Discusses HIV Treatment Science at 2016 Ryan White Conference

As the 2016 National Ryan White Conference on HIV Care and Treatment wound down in Washington, DC, NIH’s Dr. Carl Dieffenbach and his colleague Anne Rancourt joined us for a conversation on Facebook Live about HIV treatment. They discussed what scientists now know about the benefits of HIV treatment and when people diagnosed with HIV…

HIV Vaccine Research: Update from NIH’s Dr. Dieffenbach from 2nd Day of AIDS 2016

As the second day of the International AIDS Conference (AIDS 2016) came to a close in Durban, South Africa, we caught up with Dr. Carl Dieffenbach again via Facebook Live to get his thoughts on some of the day’s highlights. He is Director of the Division of AIDS at NIH’s National Institute of Allergy and…

NIH Statement on HIV Vaccine Awareness Day

Advances in HIV/AIDS research have given us the opportunity to transform the lives of those living with HIV while providing highly effective methods of preventing the infection. This progress has strengthened optimism for achieving a durable end to the HIV/AIDS pandemic. With an estimated two million new HIV infections occurring worldwide annually, however, controlling and…

HIV Vaccine and Cure Research Highlights from IAS 2015

As the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) came to a close in Vancouver, Canada, we spoke one last time by Skype with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), to learn about some of the…

NIH’s Dr. Carl Dieffenbach Shares Highlights as IAS 2015 Begins

After the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) got underway in Vancouver, Canada yesterday, July 20, we spoke by Skype with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). He shared some highlights from the first full…

BULLETIN: HIV Vaccine Awareness Day 2015

May 18, 2015 Vaccination has historically been the best method for protecting against and ultimately defeating mankind’s most devastating infectious diseases. Although the path to developing a safe and effective HIV vaccine has so far been difficult, achieving this goal remains key to realizing a durable end to the global HIV/AIDS pandemic. HIV vaccine development…

Statement from Ambassador Deborah L. Birx, M.D., U.S. Global AIDS Coordinator & U.S. Special Representative for Global Health Diplomacy, on HIV Vaccine Awareness Day

Editor’s Note: The following statement was released on Friday, May 15 by Ambassador Deborah L. Birx, The United States President’s Emergency Plan for AIDS Relief (PEPFAR) to commemorate today’s observance of HIV Vaccine Awareness Day. May 15, 2015 With no current cure for HIV/AIDS, an HIV vaccine could be a game changer in our effort…